B
Agenda

The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Implications for Global Health and Opportunities for Novel Intervention Strategies


September 21–22, 2010

Keck Building, Room 100

500 Fifth Street, NW

Washington, DC


DAY 1: Tuesday, September 21, 2010

8:00–8:30:

Registration and Continental Breakfast

8:30–8:45:

Welcoming Remarks

 

David Relman, M.D., Chair, and James Hughes, M.D., Vice-Chair, Forum on Microbial Threats

8:45–10:15:

Keynote Remarks

 

David Relman, Moderator

8:45–9:30

Opportunities for medical diplomacy: The Global Health Initiative

 

Ezekiel Emanuel, M.D., Ph.D., White House Office of Management and Budget



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 523
B Agenda The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Implications for Global Health and Opportunities for Novel Intervention Strategies September 21–22, 2010 Keck Building, Room 100 500 Fifth Street, NW Washington, DC DAY 1: Tuesday, September 21, 2010 8:00–8:30: Registration and Continental Breakfast 8:30–8:45: Welcoming Remarks David Relman, M.D., Chair, and James Hughes, M.D., Vice-Chair, Forum on Microbial Threats 8:45–10:15: Keynote Remarks David Relman, Moderator 8:45–9:30 Opportunities for medical diplomacy: The Global Health Initiative Ezekiel Emanuel, M.D., Ph.D., White House Office of Management and Budget 523

OCR for page 523
524 NEGLECTED TROPICAL AND ZOONOTIC DISEASES 9:30–10:15 NTDs slated for elimination and eradication Donald Hopkins, M.D., M.P.H., The Carter Center 10:15–10:45: Discussion 10:45–11:00: Break Session One: An Overview of the NTDs James Hughes, Moderator 11:00–11:30: Neglected infections of poverty in the United States Peter Hotez, M.D., Ph.D., The George Washington University 11:30–12:00: NTDs in the setting of conflict Chris Beyrer, M.D., M.P.H., Johns Hopkins University 12:00–12:30: Parasite prevalence and the worldwide distribution of cognitive ability Christopher Eppig, University of New Mexico 12:30–1:00: Discussion of Session One 1:00–1:45: Lunch Session Two: Global Burden of Disease/Opportunities for Control Mary Wilson, Moderator 1:45–2:15: The social and environmental context of infectious diseases occurrence in Brazil: Interventions, policies, and research needs Mauricio Barreto, M.D., M.P.H., Ph.D., Federal University of Bahia in Salvador, Brazil 2:15–2:45: Neglected tropical and zoonotic diseases and their impact on women and children’s health Marian McDonald, Dr.P.H., M.P.H., M.A., Centers for Disease Control and Prevention

OCR for page 523
525 APPENDIX B 2:45–3:15: Addressing the social determinants of the NTDs in devising an integrated control strategy Jerry Spiegel, Ph.D., M.A., M.Sc., University of British Columbia 3:15–3:30: Break 3:30–4:00: Reemergence of dengue in the United States? Harold Margolis, M.D., Centers for Disease Control and Prevention 4:00–4:30: Chagas disease in the Americas: Health impacts and opportunities for control Rick L. Tarleton, Ph.D., The University of Georgia and The Chagas Disease Foundation 4:30–5:00: Schistosomiasis Charles King, M.D., M.S., Case Western Reserve University 5:00–5:30: Progress in the control and elimination of human African trypanosomiasis Jean Jannin, M.D., World Health Organization 5:30–6:00: Integrated control of tropical diseases: Progress in the control and elimination of lymphatic filariasis Eric Ottesen, M.D., The Task Force for Global Health 6:00–6:30: Discussion of Session Two; Open Discussion of Day One 6:30: Adjourn DAY 2: September 22, 2010 8:00–8:15: Continental Breakfast 8:15–8:30: Summary of Day One: James M. Hughes, M.D., Vice-Chair, Forum on Microbial Threats Keynote Remarks: Christy Hanson, Ph.D., U.S. Agency for 8:30–9:00: International Development James M. Hughes, Moderator

OCR for page 523
526 NEGLECTED TROPICAL AND ZOONOTIC DISEASES 9:00–9:15: Discussion Session Three: Governmental and Nongovernmental Approaches to Integrated Disease Control Kevin Russell, Moderator 9:15–9:45: Neglected zoonotic diseases Lonnie King, D.V.M., The Ohio State University 9:45–10:15: Regional approaches to NTD control in the Americas Steven Ault, Pan American Health Organization 10:15–10:45: The neglected tropical diseases in Africa and next steps for global control and elimination Lorenzo Savioli, M.D., M.Sc., DTM&H, World Health Organization 10:45–11:00: Break 11:00–11:30: The U.K. commitment to NTD control Alan Fenwick, Imperial College of London 11:30–12:00: The Gates Foundation commitment to NTD control Julie Jacobson, M.D., DTM&H, The Bill & Melinda Gates Foundation 12:00–12:30: Discussion 12:30–1:15: Luncheon Remarks: Jesse Goodman, M.D., M.P.H., Chief Scientist, Food and Drug Administration “Can we collaborate to develop new paradigms and approaches for public health product development and evaluation?” Session Four: Unmet Needs: Development of Diagnostics, Drugs, and Vaccines to Control or Treat the Most Common NTDs David Relman, Moderator 1:15–1:45: Public–private partnerships addressing diseases of the developing world: Lessons learned; current challenges; future opportunities Mark Feinberg, M.D., Ph.D., Merck & Co.

OCR for page 523
527 APPENDIX B 1:45–2:15: New drugs in clinical development Shing Chang, Ph.D., DNDi 2:15–2:45: Need for improved diagnostics Patrick Lammie, Ph.D., M.S., Centers for Disease Control and Prevention 2:45–3:00: Break 3:00–3:30: R&D Investments Mary Moran, M.D., Policy Cures, Sydney, Australia, London, UK 3:30–4:00: Antihelminthic vaccines Peter Hotez, M.D., Ph.D., The George Washington University 4:00–4:45: Open Panel Discussion 4:45–5:00: Closing Remarks James Hughes and David Relman 5:00: Meeting Adjourned

OCR for page 523